Burden of Alzheimer's disease and association with negative health outcomes

American Journal of Managed Care

Volumn 15, Issue 8, 2009, Pages 481-488

  Malone, Daniel C ^a   McLaughlin, Trent P ^b   Wahl, Peter M ^c   Leibman, Christopher ^b   Arrighi, H Michael ^b   Cziraky, Mark J ^c   Mucha, Lisa M ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b ELAN PHARMACEUTICALS   (United States)

^c HEALTHCORE INC   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; EMERGENCY CARE; FEMALE; FRACTURE; GEOGRAPHY; HEALTH; HEALTH CARE PLANNING; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OUTCOME ASSESSMENT; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; RISK; SEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; DRUG THERAPY; FEMALE; FRACTURES, BONE; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 69749104112     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Edison P, Archer HA, Hinz R, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68(7):501-508. (Pubitemid 46263180)
2. Alzheimer's Association. Alzheimer's Disease Facts and Figures, 2007. Chicago, IL: Alzheimer's Association; 2007:30.
3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186-191. (Pubitemid 46825511)
4. Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care. 2001;7(8):809-818. (Pubitemid 32815961)
5. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551-2556.
6. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002;58(1):62-70. (Pubitemid 34041939)
7. Dixon S, Walker M, Salek S. Incorporating carer effects into economic evaluation. Pharmacoeconomics. 2006;24(1):43-53. (Pubitemid 43197230)
8. Morris JC, Rubin EH, Morris EJ, Mandel SA. Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol. 1987;42(4):412-417.
9. Weller I, Schatzker J. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol. 2004;14(5):319-324. (Pubitemid 38737324)
10. Sheridan PL, Hausdorff JM. The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24(2):125-137.
11. Fillenbaum G, Heyman A, Peterson BL, Pieper CF, Weiman AL. Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI. Neurology. 2001;56(2):201-206. (Pubitemid 32095361)
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
13. Joyce AT, Yang J, Bowman L, Flynn JA, Carter CT, Ollendorf DA. Burden of illness among commercially insured patients with Alzheimer's disease. Alzheimers Dement. 2007;3(3):204-210. (Pubitemid 46825504)
14. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA. 1987;257(11):1492-1495.
15. Koutsavlis AT, Wolfson C. Elements of mobility as predictors of survival in elderly patients with dementia: findings from the Canadian Study of Health and Aging. Chronic Dis Can. 2000;21(3):93-103. (Pubitemid 30944691)
16. Imamura T, Hirono N, Hashimoto M, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol. 2000;7(1):77-79. (Pubitemid 32268739)
17. Melton LJ 3rd, Beard CM, Kokmen E, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc. 1994;42(6):614-619.
18. Guo Z, Wills P, Viitanen M, Fastbom J, Winblad B. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148(9):887-892. (Pubitemid 28484108)
19. Ranstam J, Elffors L, Kanis JA. A mental-functional risk score for prediction of hip fracture. Age Ageing. 1996;25(6):439-442. (Pubitemid 26418172)
20. Greenspan SL, Myers ER, Kiel DR Parker RA, Hayes WC, Resnick NM. Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med. 1998;104(6):539-545.
21. Visser H. Gait and balance in senile dementia of Alzheimer's type. Age Ageing. 1983;12(4):296-301. (Pubitemid 15040702)
22. Alexander NB, Mollo JM, Giordani B, et al. Maintenance of balance, gait patterns, and obstacle clearance in Alzheimer's disease. Neurology. 1995;45(5):908-914.
23. Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004;164(14):1567-1572.
24. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989;262(23): 3303-3307. (Pubitemid 20012552)
25. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319(26): 1701-1707. (Pubitemid 19019577)
26. Gales BJ, Menard SM. Relationship between the administration of selected medications and falls in hospitalized elderly patients. Ann Pharmacother. 1995;29(4):354-358.
27. Thapa PB, Gideon P, Fought RL, Ray WA. Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol. 1995;142(2):202-211.
28. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med. 2002;34(7):528-535. (Pubitemid 34779108)